CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo

28th May 2026 Uncategorised 0

The top pharmacy benefit manager in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, allowing a significant number of patients to gain access to the drugs through their existing insurance.

More: CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
Source: fierce